Donghua Yin

Donghua Yin has extensive experience in oncology clinical pharmacology, having served in various leadership roles at Pfizer from January 2015 to January 2023, including Vice President and Head of Oncology Clinical Pharmacology and Vice President and Head of Clinical Pharmacology for Early Oncology Development. Prior to this, Donghua Yin was a Senior Director in Clinical Pharmacology at Pfizer and worked as a Senior Research Scientist at Pharmacia Corporation from June 2001 to July 2003. Also notable is a postdoctoral role at The Ohio State University and a faculty position at Nanjing Medical University. Donghua Yin holds a Ph.D. in Pharmaceutics from The University of Tennessee Health Science Center and a Master's degree from China Pharmaceutical University.